our team

Gordana Gregurić Čičak, MD Chief Executive Officer

Gordana joined the CRO industry in 1998 in the role of Medical Research Associate and since then has gained over 20 years of working experience in the international clinical research arena.

Gordana has excelled in both Clinical Project Management and Senior Management positions within leading Global (Ingenix, i3 research) and Regional/International CRO companies (SAR Monitoring Services, Ergomed), including managing Regional and Country business responsibilities.

She was a Board Member of the Ingenix Pharmaceutical Services (i3 research) in Croatia. In 2006 she became the Co-founder and CEO of Optimapharm.

Gordana graduated from the Medical School, University of Zagreb in 1995. In 2001, she completed postgraduate studies in Clinical Pharmacology with Toxicology.

Christophe Lyssens, MSc Vice President Clinical Operations

Christophe holds a Master of Science in Biology from the University of Antwerp (Belgium). After working on University Research projects, Christophe started his career in the pharma industry in 2003.

He worked in different positions of increasing responsibility at a CRO, global Pharma and Biotech company.

Christophe then joined a Global CRO in 2011 as senior Clinical Vendor Manager EMEA and was responsible for the selection, contracting, quality and performance of partner CROs in the EMEA region.

In 2014 he received additional responsibility as the Country Head for Greece.

Christophe joined Optimapharm in 2015 as Vice President Clinical Operations and Country Manager for Belgium.

Mirna Šenjug Novak, MA in Economics, CFA Chief Financial Officer

Mirna is a finance expert with extensive experience in investment banking, controlling, and finance management. Her career started in the investment banking division of Intesa Sanpaolo PBZ.

Mirna has worked on many industry and company analyses, company valuations, business planning and M&A transactions gaining valuable experience in financial modeling, strategic planning and market research.

Later, she was responsible for setting up the controlling department in a regional commercial bank, working closely with the Management and Supervisory Board on strategic planning, ALM, external audits and investor relations. In 2012 Mirna joined Optimapharm's team as Chief Financial Officer.

Igor Čičak, MA in Economics President of Supervisory Board

Igor is a banker, an investor and an entrepreneur with over 20 years of relevant experience and with a strong track record of successful investments. Igor started his banking career in 1997 with Bank Austria Group and from 2003-2005 he has performed position as the Head of Corporate banking at HVB Group in Croatia.

During the period from 2005-2006 Igor served as a Board Member of a leading regional food & retail company with sales over €6B.

From 2006-2011 Igor was a CEO of commercial regional bank.

Igor is a co-founder of Optimapharm and serves as President of the Supervisory Board since 2011.

Igor is also a founder of Provectus Capital, investment banking firm active in SEE region.

Education: London Business School - Senior Executive Programme (2014);
General Management Program Wirtschaftsuniversität Wien, Austria (2004);
1990 – 1995: Faculty of Economic Science, University of Zagreb, B. Sci. Economics.


Chris is a seasoned financial professional with over 20 years’ experience in providing structured finance and equity capital to companies in both Western and Central & Eastern Europe.

Since 2005 Chris has been a partner at Mezzanine Management, the first dedicated mezzanine fund manager for Central and Eastern Europe. It manages four funds with total funds raised of over EUR 840 million. The latest fund, AMC Capital Capital IV ScSP was established in mid-2017 with EUR 264 million committed capital. The four funds have made 49 investments in 12 countries of the central and eastern European region to date.

Between 2000 and 2005 Chris was head of Acquisition Finance, Central and Eastern Europe at Erste Bank where he was a pioneer in the region’s fledgling acquisition finance market.

Before joining Erste Bank in 1997, he was Investment Manager at HSBC Ventures, a private equity operation focusing on small buy-outs in the UK.

Chris is British and lives in Prague. He holds a Bachelor of Science degree from Loughborough University and a Diploma in Marketing.